Fri, Aug 1, 2014, 12:01 PM EDT - U.S. Markets close in 3 hrs 59 mins

Recent

% | $
Click the to save as a favorite.

Astex Pharmaceuticals, Inc. Message Board

  • weightbayou weightbayou Jul 9, 2013 8:45 AM Flag

    Astex awarded another patent

    United States Patent 8,481,531
    Saxty , et al. July 9, 2013

    --------------------------------------------------------------------------------
    Bicyclic heterocyclyl derivatives as FGFR kinase inhibitors for therapeutic use

    Abstract
    The invention relates to new bicyclic heterocyclyl derivatives of formula (I), to pharmaceutical compositions comprising said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.

    --------------------------------------------------------------------------------
    Inventors: Saxty; Gordon (Cambridge, GB), Berdini; Valerio (Cambridge, GB), Freyne; Eddy Jean Edgard (Rumst, BE), Papanikos; Alexandra (Antwerp, BE), Benderitter; Pascal (Orbe, CH), Embrechts; Werner Constant Johan (Beerse, BE), Wroblowski; Berthold (Vosselaar, BE), Akkari; Rhalid (Vacquieres, FR)
    Applicant: Name City State Country Type

    Saxty; Gordon
    Berdini; Valerio
    Freyne; Eddy Jean Edgard
    Papanikos; Alexandra
    Benderitter; Pascal
    Embrechts; Werner Constant Johan
    Wroblowski; Berthold
    Akkari; Rhalid
    Cambridge
    Cambridge
    Rumst
    Antwerp
    Orbe
    Beerse
    Vosselaar
    Vacquieres
    GB
    GB
    BE
    BE
    CH
    BE
    BE
    FR

    Assignee: Astex Therapeutics Ltd (Cambridge, GB)

    Appl. No.: 13/264,593
    Filed: April 15, 2010

    Sentiment: Strong Buy

 
ASTX
8.4950.000(0.00%)Oct 10 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.